RGTI's chiplet tech, Azure integration, and solid financials put it ahead of IONQ as Microsoft fuels quantum's cloud future.

NVIDIA's Q2 earnings spark debate as AI-driven growth, record GPU demand, and steep valuation fuel both optimism and caution.

NEW HAVEN, Conn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will host an investor call and live webcast at 8 a.m.

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against SelectQuote, Inc. (“SelectQuote” or “the Company”) (NYSE: SLQT) and certain of its officers.

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Tesla, Inc. (“Tesla” or “the Company”) (NASDAQ: TSLA) and certain of its officers.

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against iRobot Corporation (“iRobot” or “the Company”) (NASDAQ: IRBT) and certain of its officers.

NEWTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer's disease, announced today that management will participate in the following upcoming investor conferences.

For the first time in its history, the digital economy faces a true energy bottleneck. Artificial intelligence and the hyperscale data centers that support it are so compute and power hungry that the existing US grid is straining to keep up and may soon be unable to meet demand.

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Investors can contact the law firm at no cost to learn more about recovering their losses

Investors can contact the law firm at no cost to learn more about recovering their losses

Ionis Pharmaceuticals remains a Buy after Dawnzera's FDA approval, which strengthens its pipeline and revenue outlook despite a history of operating losses. Dawnzera's market opportunity in hereditary angioedema is significant, with potential for near-blockbuster status if it captures a 20% share of a ~$5bn market. Upcoming catalysts — including olezarsen's sHTG data and eplontersen's ATTR-CM results — could drive Ionis toward profitability and a higher valuation.

How investors can use a Zacks screen to help find some of the best Zacks Rank #1 (Strong Buy) stocks to buy in September and beyond.

CHARTER COMMUNICATIONS, INC. (NASDAQ: CHTR) INVESTOR ALERT: Investors With Large Losses in Charter Communications, Inc. Should Contact Bernstein Liebhard

CoreWeave is a key AI infrastructure player but faces execution, growth, and profitability challenges, with recent results highlighting inflated expectations and stock volatility. The pending Core Scientific acquisition offers strategic data center expansion and cost synergies, but comes with dilution and execution risks. Q2 results showed strong revenue and backlog growth, but rising capital expenditures and margin pressures have led to a sharp stock pullback.

A KBW analyst still prefers big banks over regional names, but sees opportunities for investors who want to chase the rally in smaller bank stocks.

For generations, utility stocks were only considered a good idea for “orphans and widows,” a term that once referred to utility stocks considered so safe and reliable that they were suitable for even extremely conservative investors, like widows and orphans.

Is Spirit Airlines about to breach the final “Frontier”?

Nebius Group N.V. demonstrates disciplined, demand-aligned expansion, avoiding the pitfalls of overextension common in hypergrowth sectors, ensuring efficient capital allocation. Q2 results showed 322% YoY topline growth and 9x AI infrastructure revenue, with gross margins soaring to 71.36% and early EBITDA positivity in core operations. Strategic capacity buildout, including pausing for next-gen Nvidia Blackwell GPUs, maximizes capital efficiency and preserves pricing power amid booming AI demand.

Investors can contact the law firm at no cost to learn more about recovering their losses